Title |
Associated Clinical and Laboratory Markers of Donor on Allograft Function After Heart Transplant
|
---|---|
Published in |
Brazilian journal of cardiovascular surgery, April 2016
|
DOI | 10.5935/1678-9741.20160025 |
Pubmed ID | |
Authors |
Braulio, Renato, Sanches, Marcelo Dias, Teixeira Junior, Antonio Lúcio, Costa, Paulo Henrique Nogueira, Moreira, Maria da Consolação Vieira, Rocha, Monaliza Angela, Andrade, Silvio Amadeu de, Gelape, Cláudio Léo |
Abstract |
Primary graft dysfunction is a major cause of mortality after heart transplantation. To evaluate correlations between donor-related clinical/biochemical markers and the occurrence of primary graft dysfunction/clinical outcomes of recipients within 30 days of transplant. The prospective study involved 43 donor/recipient pairs. Data collected from donors included demographic and echocardiographic information, noradrenaline administration rates and concentrations of soluble tumor necrosis factor receptors (sTNFR1 and sTNFR2), interleukins (IL-6 and IL-10), monocyte chemoattractant protein-1, C-reactive protein and cardiac troponin I. Data collected from recipients included operating, cardiopulmonary bypass, intensive care unit and hospitalization times, inotrope administration and left/right ventricular function through echocardiography. Recipients who developed moderate/severe left ventricular dysfunction had received organs from significantly older donors (P =0.020). Recipients from donors who required moderate/high doses of noradrenaline (>0.23 µg/kg/min) around harvesting time exhibited lower post-transplant ventricular ejection fractions (P =0.002) and required longer CPB times (P =0.039). Significantly higher concentrations of sTNFR1 (P =0.014) and sTNFR2 (P =0.030) in donors were associated with reduced intensive care unit times (≤5 days) in recipients, while higher donor IL-6 (P =0.029) and IL-10 (P =0.037) levels were correlated with reduced hospitalization times (≤25 days) in recipients. Recipients who required moderate/high levels of noradrenaline for weaning off cardiopulmonary bypass were associated with lower donor concentrations of sTNFR2 (P =0.028) and IL-6 (P =0.001). High levels of sTNFR1, sTNFR2, IL-6 and IL-10 in donors were associated with enhanced evolution in recipients. Allografts from older donors, or from those treated with noradrenaline doses >0.23 µg/kg/min, were more frequently affected by primary graft dysfunction within 30 days of surgery. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 11% |
Student > Master | 3 | 11% |
Student > Bachelor | 3 | 11% |
Librarian | 2 | 7% |
Other | 2 | 7% |
Other | 5 | 18% |
Unknown | 10 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 46% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Materials Science | 1 | 4% |
Veterinary Science and Veterinary Medicine | 1 | 4% |
Unknown | 11 | 39% |